| Name | Title | Contact Details |
|---|
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
We are the leading promotional marketing SaaS solution that enables brands to increase sales, engage audiences, and access rich analytics, by leveraging incentives to drive awareness, conversion and loyalty. Smartify’s technology automates and optimizes many of the features associated with traditional promotional marketing, including: Reporting, Program Management, Prize Fulfillment, Winner Notification, Rules, and Administration. Smartify is growing rapidly through relationships developed directly with brands and agencies. Clients include: Cost Plus World Market, NBCUniversal, Bed Bath and Beyond, Delta, Redbox, Hyundai, and Intel.
Bastille senses, identifies and localizes Radio threats, providing security teams the ability to accurately quantify risk and mitigate airborne threats that could pose a danger to network infrastructure.
DistroScale offers a complete, scalable solution to tap into the power of video. Making video possible for every audience, on every platform.